Phase 2 Acute promyelocytic leukaemia Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Completed
Phase 2
A phase II trial in patients with acute promyelocytic leukaemia (APML) to evaluate the effects of: all-trans retinoic acid combined with intensive idarubicin during induction and consolidation; subsequent intermittent all-trans retinoic acid; and molecular monitorting for evidence of minimal residual leukaemia and for evidence of incipient relapse.
Acute promyelocytic leukaemia
Australasian Leukaemia and Lymphoma Group100 enrolled1 locationACTRN12607000410459
Completed
Phase 2
Acute Promyelocytic Leukaemia APML4 Protocol
Acute promyelocytic leukaemia (APL)
Australasian Leukaemia and Lymphoma Group125 enrolled28 locationsACTRN12605000070639